Day Zero Diagnostics Names Jeff Mirviss Chair of Board of Directors
Day Zero Diagnostics announced today that independent board member, Jeff Mirviss, has been appointed board chair.
Article Date
October 24, 2023
This article is featured on another website.
Go to article
June 26, 2024
CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
June 26, 2024
CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
June 4, 2024
Now Available: Myrtelle ASGCT Symposium Presentation
Myrtelle shared clinical trial updates and future directions for Oligodendrocyte targeting AAVs at the 27th Annual Meeting of the ASGCT.
June 4, 2024
Now Available: Myrtelle ASGCT Symposium Presentation
Myrtelle shared clinical trial updates and future directions for Oligodendrocyte targeting AAVs at the 27th Annual Meeting of the ASGCT.